Exhibitor list

Our Exhibitors

Contrad Swiss SA

Contrad Swiss SA

J25

6900 Lugano
Switzerland
https://contrad.ch/

We are Contrad Swiss, a pharmaceutical company focused on making a change in people’s life. We pride ourselves on breakthrough, innovative products that reframe the world of medicine to bring you effective biomimicry remedies unlike any other.
We are the SIGMOLECS® company.
SIGMOLECS® Technology was conceived and engineered by Dr JO Serrentino, exclusively for Contrad Swiss. SIGMOLECS® uses signaling molecules to summon and target biological pathways to repair, for precise programming at the cellular level. These signaling molecules occur naturally in plants and animals and are characterized by specific amino acid sequences that signal each phase of growth and every physiological function. Our technology synthesizes and purifies these naturally-occurring molecules with the sequences that occur at each of the natural phases, in order to duplicate their biological action. The result is like a program code of the cells deploying them to organize into specific patterns that can repair and renew tissue.
It is basically like writing a program for the cells of the body. SIGMOLECS® talks to the cells in their language.

Products

Product news

  • SIGMOLECS®: the most advanced Technology available for Regenerative Medicine

    Contrad Swiss, a pharmaceutical company focused on breakthrough, innovative products that reframe the world of medicine, announces a new partnership with Dr JO Serrentino to bring to the market effective biomedical remedies unlike any other.

    SIGMOLECS® Technology was conceived and engineered by Dr Serrentino exclusively for Contrad Swiss. SIGMOLECS® uses the highest bioavailable signaling molecules to summon and target biological pathways for precise programming at the cellular level. The result is like a program code of the cells, deploying them to organize into specific patterns.

    ACTV8SKN® – Actuator - contains the exclusive SIGMOLECS® Technology.
    ACTV8SKN® is an odorless fluid gel of peptide-bonded amino acids, specifically engineered for a complete signaling spectrum that awakens cell cycles of the skin. It can be used in clinic to enhance procedures or dispensed to patients as a follow up take-home product.

    Information on the development, novel characteristics of SIGMOLECS® Technology and clinical data supporting the long-lasting efficacy of the most advanced regenerative cosmetic available today, can be requested. www.contrad.ch

    About Dr JO Serrentino
    M.Sc; DVM; Ph.D FAARM; DABRM. Master’s in Biochemistry; Veterinarian; Doctorate in clinical ecology/environmental medicine. Fellow of the American Academy of Regenerative Medicine; Diplomat of the American Board of Regenerative Medicine.
    Extensive expertise in the following areas:
    • Protein sequencing and clones for biological new medicine;
    • Peptide inclusion for medicine;
    • Use of cytokines in medicine and therapy and as pathophysiological markers.
    • Biological markers for diagnostics; targeting and research& development
    • Carrier formulations for enhanced absorption of active principles; formulating, assessment and/or amendment
    • Molecular manipulation for enhanced biological properties esp. with protein (cytokine) and gene therapy;
    • Stem cell extenders and methodologies for clinical application.

    https://contrad.ch/innovation.php